GSI 255 (Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg)

Generic Name: emtricitabine/rilpivirine/tenofovir alafenamide

This pill with imprint "GSI 255" is Gray, Capsule-shape and has been identified as Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg. It is supplied by Gilead Sciences, Inc..

Odefsey is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Odefsey

Generic Name:

emtricitabine/rilpivirine/tenofovir alafenamide

Imprint:

GSI 255

Strength:

emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg

Color:

Gray

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antiviral combinations

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Gilead Sciences, Inc.

National Drug Code (NDC):

61958-2101

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.